The U.S. Justice Dept. and the Federal Trade Commission are investigating Valeant Pharmaceuticals (NYSE:VRX, TSE:VRX) subsidiaries Bausch & Lomb and Paragon Vision Sciences, the Canadian drug maker said yesterday. The Justice Dept. is looking into payments Bausch & Lomb made to doctors using its Crystalens intra-ocular lens and Victus eye laser, Valeant said yesterday in a regulatory […]
Federal Trade Commission (FTC)
Steris, Synergy delay shareholder votes ahead of anti-trust ruling on $2B merger
Steris (NYSE:STE) and Synergy Health postponed their shareholders meetings to give a U.S. court time to rule on the Federal Trade Commission’s bid to halt their $1.9 billion merger. Mentor, Ohio-based Steris said it moved its meeting from Sept. 24 to Oct. 2; Synergy plans to hold its vote the same day, according to a regulatory filing. Earlier […]
FDA approves STJ’s MRI-safe SCS device | Regulatory news for the week of May 4, 2015
FTC: We might force M&A divestitures in outside markets
The U.S. Federal Trade Commission last week said it may force companies to divest assets outside of the market the anti-monopoly bureau its trying to regulate.
Cardinal Health to pay $27m to settle FTC anti-trust charges
Feds indict ex-Acclarent execs | The week in medtech M&A
U.S. regulators OK $1.4B Sorin-Cyberonics tie-up
Zimmer extends deadline for $13B Biomet deal
Regulators deal WMGI double whammy | Regulatory news for the week of February 9, 2015
Regulators deal Wright Medical a double whammy
FTC wants more from Steris, Synergy on inversion merger
